Development of a questionnaire to assess the quality of care in Dutch dialysis centers from the patient's perspective.

Expert Rev Pharmacoecon Outcomes Res

University Medical Center, Institute for Medical Technology Assessment, Erasmus MC, PO Box 1738, 3000 DR Rotterdam, The Netherlands.

Published: June 2005

This study aimed to develop and test a questionnaire in order to assess the quality of care in Dutch dialysis centers from the patient's perspective. The questionnaire is referred to as the Quality of Care in Dialysis centers Questionnaire. Focus group sessions were organized and the results were transformed into a 68-item test version of the Quality of Care in Dialysis centers Questionnaire. Factor analyses and item reduction were performed to construct the Quality of Care in Dialysis centers Questionnaire. The questionnaire has four dimensions: doctors, nurses, other staff members and facilities; with eight descriptive items plus one item to measure satisfaction per dimension. A visual analog scale was added to determine overall satisfaction. The Quality of Care in Dialysis centers Questionnaire is used in Dutch dialysis centers. Further research should be conducted to establish preference weights per dimension on the basis of the visual analog scale scores.

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.5.3.255DOI Listing

Publication Analysis

Top Keywords

dialysis centers
28
quality care
24
care dialysis
16
centers questionnaire
16
dutch dialysis
12
assess quality
8
care dutch
8
centers patient's
8
patient's perspective
8
visual analog
8

Similar Publications

Introduction: Bone turnover markers reflected the bone remodeling process and bone health in clinical studies. Studies on variation of bone remodeling markers in different stage CKD were scant, and this study investigated the role of bedside intradialytic cycling in altering concentrations of bone-remodeling markers in patients with end-stage renal disease (ESRD).

Materials And Methods: Participants were segmented into four groups: a group with eGFR >60 ml/min/1.

View Article and Find Full Text PDF

Introduction: Neonatal seizures are the most common clinical manifestation of neurological dysfunction in newborns, with an incidence ranging from 1 to 5‰. However, the therapeutic efficacy of current pharmacological treatments remains suboptimal. This study aims to utilize genetically modified hamsters with hypertriglyceridaemia (HTG) to investigate the effects of elevated triglycerides on neuronal excitability and to elucidate the underlying mechanisms.

View Article and Find Full Text PDF

Rational & Objective: Majority of people with end-stage kidney disease (ESKD) are sedentary, which increases risk for decreased quality and quantity of life. Development of exercise programs with characteristics that address individual preferences may increase interest in participating and completing exercise programs. We evaluated which exercise intervention characteristics affect exercise program recruitment, adherence, and completion in people with ESKD receiving dialysis.

View Article and Find Full Text PDF

Renal Outcomes With Renin-Angiotensin System Blockers After Unilateral Nephrectomy.

Kidney Int Rep

January 2025

Division of Nephrology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Introduction: Despite the benefits of renin-angiotensin system (RAS) blockers, their immediate use after nephrectomy has been limited because of concerns about impaired renal adaptation. We aimed to evaluate the effect of RAS blockers immediately after unilateral nephrectomy on renal adaptation.

Methods: This single-center retrospective cohort study included 580 patients who underwent elective unilateral nephrectomy between 2010 and 2020 and had preexisting hypertension with antihypertensive medications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!